Australia's most trusted
source of pharma news
Monday, 27 July 2026
Posted 27 July 2026 AM
A new AI platform is making it easier for patients to have their say during PBAC consultations.
Developed by Boehringer Ingelheim in partnership with patient advocacy groups, Patient Input Buddy uses conversational language and guides users through a series of questions to help patients share their lived experience and prepare and submit contributions.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.